Insider Buying: Neogen Co. (NASDAQ:NEOG) Director Purchases 7,500 Shares of Stock

Neogen Co. (NASDAQ:NEOG - Get Free Report) Director James C. Borel purchased 7,500 shares of the company's stock in a transaction on Thursday, April 11th. The shares were purchased at an average cost of $13.06 per share, with a total value of $97,950.00. Following the transaction, the director now directly owns 21,392 shares in the company, valued at $279,379.52. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.

Neogen Stock Up 4.0 %

Shares of Neogen stock opened at $13.00 on Friday. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.82 and a quick ratio of 2.63. The company has a 50-day moving average of $15.88 and a 200 day moving average of $16.77. The firm has a market cap of $2.82 billion, a price-to-earnings ratio of 1,301.30 and a beta of 1.13. Neogen Co. has a 1 year low of $12.18 and a 1 year high of $24.09.

Neogen (NASDAQ:NEOG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 9th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.02). The business had revenue of $228.80 million during the quarter, compared to the consensus estimate of $230.01 million. Neogen had a return on equity of 3.35% and a net margin of 0.17%. The firm's revenue was up 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.12 earnings per share. As a group, sell-side analysts anticipate that Neogen Co. will post 0.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades


Have You Seen Elon’s New A.I. Device? (Picture Inside)
A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...
This strange new device to protect us against that A.I. threat...


Separately, Piper Sandler upped their price objective on shares of Neogen from $17.50 to $19.00 and gave the stock a "neutral" rating in a report on Thursday, January 18th.

Get Our Latest Stock Report on Neogen

Institutional Trading of Neogen

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Moody National Bank Trust Division bought a new stake in Neogen during the 1st quarter valued at about $161,000. Napatree Capital LLC bought a new stake in Neogen during the 4th quarter valued at about $788,000. Vanguard Group Inc. increased its stake in Neogen by 9.3% during the 4th quarter. Vanguard Group Inc. now owns 19,546,737 shares of the company's stock valued at $393,085,000 after purchasing an additional 1,663,125 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Neogen by 4.3% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 118,149 shares of the company's stock valued at $2,376,000 after purchasing an additional 4,848 shares in the last quarter. Finally, O Dell Group LLC bought a new stake in Neogen during the 4th quarter valued at about $37,000. 96.73% of the stock is currently owned by institutional investors.

About Neogen

(Get Free Report)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.

See Also

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Neogen?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Neogen and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles